Elecsys Anti-HBc II

STN: 125804/0
Proper Name: Elecsys Anti-HBc II
Tradename: Elecsys Anti-HBc II
Manufacturer: Roche Diagnostics

Indication:

Elecsys Anti-HBc II is an in vitro immunoassay for the qualitative detection of antibodies to hepatitis B core antigen (anti-HBc) in human serum and plasma. Elecsys Anti-HBc II is intended to screen individual human donors, including volunteer donors of whole blood and blood components. The assay is also intended to be used to screen organ, tissue and cell donors, when donor samples are obtained while the donor’s heart is still beating. It is not intended for use on cord blood specimens.

The electrochemiluminescence immunoassay “ECLIA” is intended for use with cobas pro serology solution-equipped with cobas e 801 analytical unit.

Production Information

Package Insert - Elecsys Anti-HBc II

Package Insert - PreciControl Anti-HBc II

Package Insert - PreciControl Release Anti-HBc II

Supporting Documents

February 27, 2024 Approval Letter - Elecsys Anti-HBc II

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

You just read:

Elecsys Anti-HBc II

Distribution channels: Healthcare & Pharmaceuticals Industry

EIN Presswire's priority is author transparency. We do our best to weed out false and misleading content. The content above is the sole responsibility of the author who makes it available. If you have any complaints, kindly contact the author above.